365
Participants
Start Date
February 28, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Exenatide once weekly suspension
Sitagliptin
Placebo
Placebo oral capsule once daily
Research Site, Hartsdale
Research Site, Buffalo
Research Site, Oxon Hill
Research Site, Burke
Research Site, Greensboro
Research Site, Clayton
Research Site, Durham
Research Site, Mooresville
Research Site, Salisbury
Research Site, Charlotte
Research Site, Greer
Research Site, Simpsonville
Research Site, Port Orange
Research Site, Hialeah
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Boca Raton
Research Site, St. Petersburg
Research Site, Birmingham
Research Site, Huntsville
Research Site, Chattanooga
Research Site, Marion
Research Site, Franklin
Research Site, Cincinnati
Research Site, Indianapolis
Reseach Site, Rapid City
Research Site, Evanston
Research Site, Chicago
Research Site, Omaha
Research Site, Yukon
Research Site, Carrolton
Research Site, Dallas
Research Site, Houston
Research Site, Houston
Research Site, Katy
Research Site, San Antonio
Research Site, Corpus Christi
Research Site, Salt Lake City
Research Site, Salt Lake City
Research Site, Phoenix
Research Site, Phoenix
Research Site, Albuquerque
Research Site, Henderson
Research Site, Las Vegas
Research Site, Las Vegas
Research Site, Beverly Hills
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Buena Park
Research Site, West Hills
Research Site, North Hollywood
Research Site, Chino
Research Site, Chula Vista
Research Site, Encinitas
Research Site, Walnut Creek
Research Site, Greenbrae
Research Site, Portland
Research Site, Eugene
Research Site, Spokane
Lead Sponsor
AstraZeneca
INDUSTRY